The authors did extensive analyses and concluded that use of IG might be associated with reduced risk for MI, but this did not reach statistical significance [ 40 ].
← all excerpts
Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis.
1
—
—